Alnylam Pharmaceuticals Change in Inventories increased by 166.8% to $3.32M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 153.5%, from -$6.22M to $3.32M. Over 3 years (FY 2021 to FY 2024), Change in Inventories shows a downward trend with a -19.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase might signal preparation for a major product launch or, conversely, slowing demand and potential future write-downs.
This metric tracks the change in the value of raw materials, work-in-progress, and finished goods held by the company. A...
Consumer hardware companies aim for high inventory turnover to minimize the risk of product obsolescence.
change_in_inventories| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.96M | $13.63M | $10.76M | -$1.93M | $9.20M | $7.88M | $18.98M | $403.00K | -$1.99M | -$4.80M | -$11.99M | -$22.00K | -$6.79M | -$5.93M | -$849.00K | -$6.22M | -$11.14M | -$4.98M | $3.32M |
| QoQ Change | — | +244.7% | -21.1% | -117.9% | +577.7% | -14.3% | +140.7% | -97.9% | -592.6% | -141.6% | -150.1% | +99.8% | <-999% | +12.8% | +85.7% | -632.0% | -79.3% | +55.3% | +166.8% |
| YoY Change | — | — | — | — | +132.6% | -42.2% | +76.4% | +120.9% | -121.6% | -160.8% | -163.2% | -105.5% | -242.3% | -23.6% | +92.9% | <-999% | -64.0% | +16.0% | +153.5% |